Quick Take: A peer-reviewed study demonstrates that MDMA-assisted psychotherapy is remarkably cost-effective when compared to currently available treatments PTSD Healthcare cost savings of MDMA-assisted psychotherapy for PTSD estimated to be greater than $103.2 million with a return of 5,553 Quality of Life Years per 1,000 patients Santa Cruz, CA, October 14, 2020 – A peer-reviewed study published today in the research…